References
- Adewuya, A. O., Afolabi, M. O., Ogundele, O. A., Ajibare, A. O., Oladipo, B. F. (2007). Psychiatric disorders among the HIV-positive population in Nigeria: A control study. Journal of Psychosomatic Research, 63(2), 203–206. doi: 10.1016/j.jpsychores.2007.03.006
- Akena, D. H., Musisi, S., & Kinyanda, E. (2010, March). A comparison of the clinical features of depression in HIV-positive and HIV-negative patients in Uganda. African Journal of Psychiatry, 13(1), 43–51. doi: 10.4314/ajpsy.v13i1.53429
- Dal-Bó, M. J., Manoel, A. L., Filho, A. O., Silva, B. Q., Cardoso, Y. S., Cortez, J., Tramujas, L., & Silva, R. M. (2013, July 19). Depressive symptoms and associated factors among PLWHA. Journal of the International Association of Physicians in AIDS Care. Advance online publication. doi:10.1177/2325957413494829
- Farley, J., Miller, E., & Zamani, A. (2010). Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: Prevalence, predictors, and association with adherence. Journal of the International Association of Physicians in AIDS Care (JIAPAC), 9, 218–226. doi: 10.1177/1545109710371133
- Gaynes, B. N., Pence, B. W., Atashili, J., O'Donnell, J., Kats, D., & Ndumbe, P. M. (2012). Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PloS One, 7(7), e41699. doi:10.1371/journal.pone.0041699
- Gutierrez, F., Navarro, A., Padilha, S., Anton, R., Masia, M., Borrás, J., & Martín-Hidalgo, A. (2005). Prediction of adverse events associated with long-term Efavirenz therapy, using plasma drug level monitoring. Clinical Infectious Diseases, 41, 1648–1653. doi: 10.1086/497835
- Kroenke, K. I., Spitzer, R. L., & Williams, J. B. (2002, March–April). The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine, 64(2), 258–266. doi: 10.1097/00006842-200203000-00008
- Levav, I., & Rutz, W. (2002). The WHO World Health Report 2001 new understanding – new hope. Retrieved from http://www.who.int/whr/2001/en/
- Nomoto, S. H., Longhi, R. M., de Barros, B. P., Croda, J., Ziff, E. B., & CastelonKonkiewitz, E. (2015). Socioeconomic disadvantage increasing risk for depression among recently diagnosed HIV patients in an urban area in Brazil: Cross-sectional study. AIDS Care, 27(8), 979–985. doi:10.1080/09540121.2015.1017442.
- Olisah, V. O., Adekeye, O., & Sheikh, T. L. (2015). Depression and CD4 cell count among patients with HIV in a Nigerian University Teaching Hospital. The International Journal of Psychiatry in Medicine (IJPM), 48(4), 253–261. doi:10.2190/PM.48.4.b
- Reust, C. E. (2011). Common adverse effects of antiretroviral therapy for HIV disease. American Family Physician, 83(12), 1443–1451.
- Unnikrishnan, B., Jagannath, V., Ramapuram, J. T., Achappa, B., & Madi, D. (2012). Study of depression and its associated factors among women living with HIV/AIDS in coastal South India. AIDS, 2012, 684972. doi:10.5402/2012/684972
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112442/MPU-social-sciences.png"})